Prague Med. Rep. 2023, 124, 94-107
https://doi.org/10.14712/23362936.2023.8
The Neuropsychiatric Aspect of the Chronic Viral Hepatitis
References
1. , L. E., Nevola, R., Lus, G., Restivo, L., Guerrera, B., Romano, C., Zampino, R., Rinaldi, L., Sellitto, A., Giordano, M., Marrone, A. (2015) Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World J. Gastroenterol. 21(8), 2269–2280.
<https://doi.org/10.3748/wjg.v21.i8.2269>
2. , L. E., Nevola, R., Rinaldi, L., Romano, C., Giordano, M. (2017) Chronic hepatitis C virus infection and depression. Clin. Liver Dis. 21(3), 517–534.
<https://doi.org/10.1016/j.cld.2017.03.007>
3. , S., Butterworth, R. F., Pomier-Layrargues, G., Vincent, C., Hassoun, Z., Baker, G. B. (2008) Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C. Neurogastroenterol. Motil. 20(6), 671–679.
<https://doi.org/10.1111/j.1365-2982.2007.01080.x>
4. Demir, N., Çelik, M., Kölgelier, S., Sümer, S., Aksöz, S., Demir, L. S., İnkaya, A. Ç. (2013) Comparison of the level of depression and anxiety in inactive hepatitis B carriers and chronic hepatitis B patients. Turk Psikiyatri Derg. 24(4), 248–252. (in Turkish)
5. , D. P., Marinho, R. T., Bicho, M., Flores, I., Fialho, R., Ouakinin, S. (2019) Hepatitis C pretreatment profile and gender differences: Cognition and disease severity effects. Front. Psychol. 10, 2317.
<https://doi.org/10.3389/fpsyg.2019.02317>
6. , I., Dahl, A. A., Haug, T. T., Neckelmann, D. (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J. Psychosom. Res. 52(2), 69–77.
<https://doi.org/10.1016/S0022-3999(01)00296-3>
7. , I., Vinaixa, C., Berenguer, M. (2017) Hepatitis C-related cirrhosis. Current status. Cirrosis por hepatitis C. Estado actual. Medicina Clínica 148(2), 78–85.
<https://doi.org/10.1016/j.medcli.2016.09.019>
8. , S., Barberini, L., Suri, J. S., Mandas, A., Costaggiu, D., Piano, P., Zaccagna, F., Lucatelli, P., Balestrieri, A., Saba, L. (2018) Resting-state functional connectivity MRI analysis in human immunodeficiency virus and hepatitis C virus co-infected subjects. A pilot study. Eur. J. Radiol. 102, 220–227.
<https://doi.org/10.1016/j.ejrad.2018.03.022>
9. , M., Pflugrad, H., Haag, K., Tillmann, H. L., Wedemeyer, H., Arvanitis, D., Hecker, H., Tountopoulou, A., Goldbecker, A., Worthmann, H., Weissenborn, K. (2017) Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?! J. Viral Hepat. 24(7), 541–550.
<https://doi.org/10.1111/jvh.12674>
10. , E., Mariño, Z., Navines, R., Oriolo, G., Pla, A., Bartres, C., Lens, S., Forns, X., Martin-Santos, R. (2020) Incidence of depression in patients with hepatitis C treated with direct-acting antivirals. Braz. J. Psychiatry 42(1), 72–76.
<https://doi.org/10.1590/1516-4446-2018-0336>
11. , U., Sunnerhagen, K. S., Westin, J., Jakobsson Ung, E., Marschall, H. U., Josefsson, A., Simrén, M. (2019) Muscle performance and fatigue in compensated chronic liver disease. Scand. J. Gastroenterol. 54(7), 925–933.
<https://doi.org/10.1080/00365521.2019.1635638>
12. , P., Staufer, K. (2008) Depression in chronic hepatitis: The virus, the drug, or the ethnic background? Liver Int. 28(4), 429–431.
<https://doi.org/10.1111/j.1478-3231.2008.01703.x>
13. , N. F., McKeating, J. A. (2012) Hepatitis C virus and the brain. J. Viral Hepat. 19(5), 301–306.
<https://doi.org/10.1111/j.1365-2893.2012.01591.x>
14. , N. F., Wilson, G. K., Murray, J., Hu, K., Lewis, A., Reynolds, G. M., Stamataki, Z., Meredith, L. W., Rowe, I. A., Luo, G., Lopez-Ramirez, M. A., Baumert, T. F., Weksler, B., Couraud, P. O., Kim, K. S., Romero, I. A., Jopling, C., Morgello, S., Balfe, P., McKeating, J. A. (2012) Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142(3), 634–643.e6.
<https://doi.org/10.1053/j.gastro.2011.11.028>
15. , Y. V., Shkilnyuk, G. G., Valko, P. O., Stolyarov, I. D., Ivashkova, E. V., Ilves, A. G., Nikiforova, I. G., Shchelkova, O. Y., Vasserman, L. I., Vais, E. E., Valko, Y. (2018) Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients. Acta Neurol. Scand. 138(5), 408–416.
<https://doi.org/10.1111/ane.12993>
16. , L. H., Weinstein, A. A., Mehta, R., Younossi, Z. M. (2019) Importance of fatigue and its measurement in chronic liver disease. World J. Gastroenterol. 25(28), 3669–3683.
<https://doi.org/10.3748/wjg.v25.i28.3669>
17. , P., Sayiner, M., Bush, H., Gerber, L. H., Younossi, Z. M. (2017) Patient-reported outcomes and fatigue in patients with chronic hepatitis C infection. Clin. Liver Dis. 21(3), 565–578.
<https://doi.org/10.1016/j.cld.2017.03.011>
18. , D., Hughes, G. (2015) Ledipasvir/sofosbuvir (Harvoni): Improving options for hepatitis C virus infection. P T 40(4), 256–276.
19. , S., Soto-Ruiz, K. M., Flores, B., Dawkins, W., Smith, I., Eagleman, D. M., Katz, Y. (2019) A rapid, mobile neurocognitive screening test to aid in identifying cognitive impairment and dementia (BrainCheck): Cohort study. JMIR Aging 2(1), e12615.
<https://doi.org/10.2196/12615>
20. , S., Renvillard, S. G., Leutscher, P., Sørensen, L. H., Østergaard, L., Eskildsen, S. F., Videbech, P. (2016) Reduced cerebral cortical thickness in non-cirrhotic patients with hepatitis C. Metab. Brain Dis. 31(2), 311–319.
<https://doi.org/10.1007/s11011-015-9752-3>
21. , K., Kim, H., Lee, J. M., Lee, K. W., Yi, N. J., Lee, H. W., Choi, Y., Suh, S. W., Hong, S. K., Yoon, K. C., Kim, H. S., Suh, K. S. (2015) Fatigue and related factors after liver transplantation. Korean J. Hepatobiliary Pancreat. Surg. 19(4), 149–153.
<https://doi.org/10.14701/kjhbps.2015.19.4.149>
22. , M., Fuller, B., Wheaton, V., Jaehnert, S., Ellis, C., Kolessar, M., Kriz, D., Anderson, J. R., Berggren, K., Olavarria, H., Sasaki, A. W., Chang, M., Flora, K. D., Loftis, J. M. (2015) A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. J. Psychosom. Res. 78(2), 184–192.
<https://doi.org/10.1016/j.jpsychores.2014.07.020>
23. , Y., Boo, S., Yoo, H. (2018a) Hepatitis B virus infection: Fatigue-associated illness experiences among Koreans. Gastroenterol. Nurs. 41(5), 388–395.
<https://doi.org/10.1097/SGA.0000000000000335>
24. , Y., Kim, J. H., Lee, H., Lee, K., Ahn, S. H. (2018b) A quantile regression approach to explain the relationship of fatigue and cortisol, cytokine among Koreans with hepatitis B. Sci. Rep. 8(1), 16434.
<https://doi.org/10.1038/s41598-018-34842-5>
25. , S., Herzig, S., Klose, L., Roggenhofer, E., Tenckhoff, H., Kaiser, T., Thöne-Otto, A., Wiese, M., Berg, T., Schroeter, M. L., Margulies, D. S., Villringer, A. (2017) Functional connectivity alterations in patients with chronic hepatitis C virus infection: A multimodal MRI study. J. Viral Hepat. 24(3), 216–225.
<https://doi.org/10.1111/jvh.12634>
26. , N. P., Ghosh, S., Abdou-Chekaraou, M., Pradat, P., Al Hawajri, N., Manirakiza, A., Laghoe, G. L., Bekondi, C., Brichler, S., Ouavéné, J. O., Sépou, A., Yambiyo, B. M., Gody, J. C., Fikouma, V., Gerber, A., Abeywickrama Samarakoon, N., Alfaiate, D., Scholtès, C., Martel, N., Le Gal, F., Lo Pinto, H., Amri, I., Hantz, O., Durantel, D., Lesbordes, J. L., Gordien, E., Merle, P., Drugan, T., Trépo, C., Zoulim, F., Cortay, J. C., Kay, A. C., Dény, P. (2018) Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults. PLoS Negl. Trop. Dis. 12(4), e0006377.
<https://doi.org/10.1371/journal.pntd.0006377>
27. , S., Ustianowski, A., Pisapia, R., Zumla, A., Ippolito, G. (2019) Viral hepatitis: Etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect. Dis. Clin. North Am. 33(4), 1045–1062.
<https://doi.org/10.1016/j.idc.2019.08.004>
28. , Y. B., Magalhães, C. B. A., Garcia, J. H. P., Viana, C. F. G., Prudente, G. F. G., Pereira, E. D. B. (2019) Association between fatigue and exercise capacity in patients with chronic liver disease awaiting liver transplantation. Arq. Gastroenterol. 56(3), 252–255.
<https://doi.org/10.1590/s0004-2803.201900000-47>
29. , D., Burke, T., Galvin, Z., Ryan, J. D., Russell, J., Murphy, A., Hegarty, J., Stewart, S., Crowe, J. (2016) Is psychosocial and cognitive dysfunction misattributed to the virus in hepatitis C infection? Select psychosocial contributors identified. J. Viral Hepat. 23(8), 584–595.
<https://doi.org/10.1111/jvh.12544>
30. , S., Mariotto, S., Ferrari, S., Calabrese, M., Zanusso, G., Gajofatto, A., Sansonno, D., Dammacco, F. (2015) Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World J. Gastroenterol. 21(42), 11974–11983.
<https://doi.org/10.3748/wjg.v21.i42.11974>
31. , M., Tangri, N., Dobbs, B., Bajaj, J., Rolfson, D., Ma, M., Ferguson, T., Bhardwaj, P., Bailey, R. J., Abraldes, J., Tandon, P. (2018) Predicting hepatic encephalopathy-related hospitalizations using a composite assessment of cognitive impairment and frailty in 355 patients with cirrhosis. Am. J. Gastroenterol. 113(10), 1506–1515.
<https://doi.org/10.1038/s41395-018-0243-0>
32. , A. (2016) Consequences of extrahepatic manifestations of hepatitis C viral infection (HCV). Postepy Hig. Med. Dosw. (Online) 70, 349–359. (in Polish)
<https://doi.org/10.5604/17322693.1199988>
33. , C., Moore, D. J., Woods, S. P., Vigil, O., Ake, C., Perry, W., Hassanein, T. I., Letendre, S. L., Grant, I.; HIV Neurobehavioral Research Center Group (2010) Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living. J. Clin. Exp. Neuropsychol. 32(6), 637–644.
<https://doi.org/10.1080/13803390903418900>
34. , T., Dirks, M., Arvanitis, D., Braun, D., Peschel, T., Worthmann, H., Schuppner, R., Raab, P., Grosskreutz, J., Weissenborn, K. (2019) Cerebral patterns of neuropsychological disturbances in hepatitis C patients. J. Neurovirol. 25(2), 229–238.
<https://doi.org/10.1007/s13365-018-0709-2>
35. , A. D., Saigal, S., Kathuria, A., Choudhary, N. S., Saraf, N. (2018) Guillain-Barré syndrome: Rare extra-intestinal manifestation of hepatitis B. Clin. J. Gastroenterol. 11(4), 312–314.
<https://doi.org/10.1007/s12328-018-0847-3>
36. , C., Rosselli, M., Zignego, A. L., Laffi, G., Milani, S. (2014) Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions. Hepatol. Res. 44(1), 9–16.
<https://doi.org/10.1111/hepr.12116>
37. , M. G. (2006) Fatigue in liver disease: Pathophysiology and clinical management. Can. J. Gastroenterol. 20(3), 181–188.
<https://doi.org/10.1155/2006/624832>
38. , M., Monaco, S. (2020) Neuroimaging findings in chronic hepatitis C virus infection: Correlation with neurocognitive and neuropsychiatric manifestations. Int. J. Mol. Sci. 21(7), 2478.
<https://doi.org/10.3390/ijms21072478>
39. , A., Shah, S. R., Bhatia, S., Chowdhury, A., Rao, P. N., Dinh, P., Knox, S. J., Gaggar, A., Subramanian, G. M., Mohan, V. G., Sood, A., Mehta, R., Sarin, S. K. (2016) Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India. Hepatol. Int. 10(6), 988–995.
<https://doi.org/10.1007/s12072-016-9728-3>
40. , B., Ross, R. L., Dieckmann, N. F., Avery, S., Bennett, R. M., Jones, K. D., Guarino, A. J., Wood, L. J. (2014) Preliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgia. J. Neuroimmunol. 277(1–2), 160–167.
<https://doi.org/10.1016/j.jneuroim.2014.10.003>
41. , P., Aglitti, A., Masarone, M., Persico, M. (2021) Viral hepatitis: Milestones, unresolved issues, and future goals. World J. Gastroenterol. 27(28), 4603–4638.
<https://doi.org/10.3748/wjg.v27.i28.4603>
42. , H., Zhou, Y., Yan, R., Ru, G. Q., Yu, L. L., Yao, J. (2019) Fatigue in chronic hepatitis B patients is significant and associates with autonomic dysfunction. Health Qual. Life Outcomes 17(1), 130.
<https://doi.org/10.1186/s12955-019-1200-3>
43. , M., Marcinowicz, P., Sokalla, D., Stańczykiewicz, B. (2017) The neuropsychiatric aspect of the HCV infection. Adv. Clin. Exp. Med. 26(1), 167–175.
<https://doi.org/10.17219/acem/37787>
44. , K., Ennen, J. C., Bokemeyer, M., Ahl, B., Wurster, U., Tillmann, H., Trebst, C., Hecker, H., Berding, G. (2006) Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 55(11), 1624–1630.
<https://doi.org/10.1136/gut.2005.080267>
45. , M. A., Lugo Iparraguirre, L. M., Dirks, M., Deb-Chatterji, M., Pflugrad, H., Goldbecker, A., Tryc, A. B.,Worthmann, H., Gess, M., Crossey, M. M., Forton, D. M., Taylor-Robinson, S. D., Itzhaki, R. F., Weissenborn, K. (2016) Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients. J. Viral Hepat. 23(1), 39–46.
<https://doi.org/10.1111/jvh.12443>
46. , W. Y., Kang, K. H., Chen, S. L., Chiu, S. Y., Yen, A. M., Fann, J. C., Su, C. W., Liu, H. C., Lee, C. Z., Fu, W. M., Chen, H. H., Liou, H. H. (2015) Hepatitis C virus infection: A risk factor for Parkinson’s disease. J. Viral Hepat. 22(10), 784–791.
<https://doi.org/10.1111/jvh.12392>
47. , S. W., Holmes, A. C. N., Saling, M. M., Everall, I. P., Nicoll, A. J. (2018) Depression, fatigue and neurocognitive deficits in chronic hepatitis C. Hepatol. Int. 12(4), 294–304.
<https://doi.org/10.1007/s12072-018-9879-5>
48. , H. S., Amin, A., Alsirafy, S., Elsayed, N. D., Abo Elfadl, S., Nasreldin, M., Enaba, D., Nawito, Z. (2018) Psychiatric and functional neuroimaging abnormalities in chronic hepatitis C virus patients: Is vasculitis a contributing factor? Arab J. Gastroenterol. 19(2), 71–75.
<https://doi.org/10.1016/j.ajg.2018.06.003>
49. , M., Clark, H. L., Multach, M. D., Walsh, E., Rosenstein, L. K., Gazarian, D. (2015) Have treatment studies of depression become even less generalizable? A review of the inclusion and exclusion criteria used in placebo-controlled antidepressant efficacy trials published during the past 20 years. Mayo Clin. Proc. 90(9), 1180–1186.
<https://doi.org/10.1016/j.mayocp.2015.06.016>
